Ensysce Biosciences, Inc. - Common Stock (NQ:ENSC)

1.110 +0.050 (+4.72%)

Streaming Delayed Price Updated: 9:30 AM EST, Jan 9, 2026 Add to My Watchlist

Price and Volume

Volume	8,132
Open	1.110
Bid (Size)	1.070 (100)
Ask (Size)	1.120 (1,000)
Prev. Close	1.060
Today's Range	1.110 - 1.110
52wk Range	0.8601 - 8.969
Shares Outstanding	3,541,262
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Ensysce Biosciences Receives EU Patent Expanding its First-in-Class ADHD Therapy with Built-In Abuse and Overdose Protection

January 08, 2026

Via ACCESS Newswire

Ensysce Biosciences Issues Annual Shareholder Letter

January 05, 2026

Via ACCESS Newswire

Performance

YTD	+18.1%	+18.1%
1 Month	-21.8%	-21.8%
3 Month	-52.4%	-52.4%
6 Month	-46.9%	-46.9%
1 Year	-86.0%	-86.0%

More News

Ensysce Biosciences Achieves Major Milestone with Initiation of Enrollment in Pivotal Phase 3 Trial of PF614, Its Next-Generation Opioid

December 09, 2025

Via ACCESS Newswire

Ensysce Biosciences Announces Broader Patent Protection for Groundbreaking MPAR(R) Overdose Protection Technology

December 02, 2025

Via ACCESS Newswire

Ensysce Biosciences Receives Positive FDA Feedback on PF614 Manufacturing Approach

November 20, 2025

Via ACCESS Newswire

Ensysce Biosciences Secures $4 Million Financing, Unlocking Up to $20 Million in Total Financing to Advance Breakthrough Pain Programs

November 17, 2025

Via ACCESS Newswire

Ensysce Biosciences Awarded $5.3 Million in Continued NIDA Support to Advance Breakthrough Opioid Overdose Protection

June 04, 2025

Via ACCESS Newswire

Ensysce Biosciences Reports Third Quarter 2025 Financial Results

November 14, 2025

Via ACCESS Newswire

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

October 13, 2025

Via Benzinga

Ensysce Biosciences Releases Symposium Highlights from PAINWeek 2025

October 10, 2025

Via ACCESS Newswire

Ensysce Biosciences Showcases Urgent Need for Safer Opioids at PAINWeek 2025 Symposium

September 04, 2025

Via ACCESS Newswire

Ensysce Biosciences' Geoff Birkett to Chair the Fierce New Product Planning Summit 2025

August 19, 2025

Via ACCESS Newswire

Ensysce Biosciences Narrows Loss in Q2 ↗

August 13, 2025

Via The Motley Fool

Ensysce Biosciences Reports Second Quarter 2025 Financial Results and Latest Program Updates

August 13, 2025

Via ACCESS Newswire

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

July 31, 2025

Via Benzinga

Ensysce Biosciences Advances Breakthrough Opioid With Built-In Overdose Protection Following Positive FDA Feedback

July 31, 2025

Via ACCESS Newswire

These stocks that are showing activity before the opening bell on Wednesday. ↗

July 23, 2025

Via Chartmill

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

July 23, 2025

Via Benzinga

Ensysce Biosciences Initiates Pivotal Phase 3 Study of PF614 - A Next-Generation Opioid - Designed to Deliver Powerful Pain Relief and Reduce Abuse

July 16, 2025

Via ACCESS Newswire

Ensysce Biosciences Accelerates PF614-MPAR-102 Study with Full Enrollment of Part 2

June 24, 2025

Via ACCESS Newswire

Ensysce Biosciences Announces Speakers for Major Symposium at PAINWeek 2025

June 11, 2025

Via ACCESS Newswire

12 Health Care Stocks Moving In Friday's After-Market Session ↗

May 16, 2025

Via Benzinga

Ensysce Biosciences Reports First Quarter 2025 Financial Results

May 13, 2025

Via ACCESS Newswire

Ensysce Biosciences Bolsters Management Team with Regulatory Expert

May 12, 2025

Via ACCESS Newswire

Ensysce Biosciences, Inc. Announces Closing of Exercise of Warrants for $2.2 Million Gross Proceeds

April 24, 2025

Via ACCESS Newswire

Frequently Asked Questions

Is Ensysce Biosciences, Inc. - Common Stock publicly traded?

Yes, Ensysce Biosciences, Inc. - Common Stock is publicly traded.

What exchange does Ensysce Biosciences, Inc. - Common Stock trade on?

Ensysce Biosciences, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Ensysce Biosciences, Inc. - Common Stock?

The ticker symbol for Ensysce Biosciences, Inc. - Common Stock is ENSC on the Nasdaq Stock Market

What is the current price of Ensysce Biosciences, Inc. - Common Stock?

The current price of Ensysce Biosciences, Inc. - Common Stock is 1.110

When was Ensysce Biosciences, Inc. - Common Stock last traded?

The last trade of Ensysce Biosciences, Inc. - Common Stock was at 01/09/26 09:30 AM ET

What is the market capitalization of Ensysce Biosciences, Inc. - Common Stock?

The market capitalization of Ensysce Biosciences, Inc. - Common Stock is 3.93M

How many shares of Ensysce Biosciences, Inc. - Common Stock are outstanding?

Ensysce Biosciences, Inc. - Common Stock has 4M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.